IRIS
MASSIRONI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.021
EU - Europa 2.956
NA - Nord America 2.050
SA - Sud America 683
AF - Africa 61
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.775
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.933
RU - Federazione Russa 1.871
SG - Singapore 1.082
CN - Cina 813
BR - Brasile 536
HK - Hong Kong 467
IT - Italia 462
VN - Vietnam 320
FR - Francia 174
DE - Germania 105
BD - Bangladesh 97
GB - Regno Unito 85
IN - India 55
AR - Argentina 53
MX - Messico 52
SE - Svezia 40
CA - Canada 39
AT - Austria 33
FI - Finlandia 33
NL - Olanda 33
PL - Polonia 33
ES - Italia 30
TR - Turchia 29
CO - Colombia 26
ID - Indonesia 25
ZA - Sudafrica 23
JP - Giappone 20
IQ - Iraq 19
EC - Ecuador 16
VE - Venezuela 13
SA - Arabia Saudita 11
PH - Filippine 10
UY - Uruguay 10
CL - Cile 9
MA - Marocco 9
PY - Paraguay 9
LT - Lituania 8
MD - Moldavia 8
PK - Pakistan 8
TN - Tunisia 8
JM - Giamaica 7
UA - Ucraina 7
DZ - Algeria 6
IE - Irlanda 6
MY - Malesia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
JO - Giordania 5
PE - Perù 5
TW - Taiwan 5
CY - Cipro 4
HN - Honduras 4
NP - Nepal 4
OM - Oman 4
BN - Brunei Darussalam 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
PT - Portogallo 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
KR - Corea 2
KW - Kuwait 2
LB - Libano 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
DK - Danimarca 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
LY - Libia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SR - Suriname 1
Totale 8.771
Salva come PNG Salva come JPEG
Città #
Singapore 558
Hong Kong 457
Dallas 445
Moscow 393
San Jose 368
Ashburn 303
Hefei 160
Lauterbourg 136
Beijing 127
Milan 120
Ho Chi Minh City 106
New York 100
Shanghai 88
Hanoi 71
São Paulo 58
Los Angeles 49
Orem 39
Santa Clara 38
Nuremberg 33
Rome 32
Council Bluffs 31
Warsaw 29
Mexico City 25
Turin 22
Montreal 21
Naples 21
Tokyo 20
Brooklyn 19
Da Nang 19
London 18
Munich 18
Rio de Janeiro 18
Amsterdam 16
Frankfurt am Main 16
Haiphong 15
Helsinki 15
Atlanta 14
Buffalo 14
Poplar 14
Stockholm 14
Chennai 13
Denver 13
Houston 13
Ankara 12
Charlotte 12
Chicago 12
Falkenstein 12
Johannesburg 12
Vienna 12
Boardman 11
Brasília 11
Curitiba 11
Lappeenranta 11
Bologna 10
Manchester 10
San Francisco 10
Genoa 9
Guangzhou 9
Mumbai 9
Phoenix 9
Thái Bình 9
Assago 8
Brescia 8
Hải Dương 8
Quito 8
Seattle 8
Baghdad 7
Bari 7
Belo Horizonte 7
Boston 7
Lawrence 7
Miami 7
Ribeirão Preto 7
Stezzano 7
Tianjin 7
Turku 7
Barnet 6
Bogotá 6
Catania 6
Columbus 6
Dhaka 6
Dublin 6
Duque de Caxias 6
Figino 6
Jakarta 6
Montevideo 6
Palermo 6
Porto Alegre 6
Princeton 6
Querétaro 6
São Gonçalo 6
Tashkent 6
Amman 5
Apodaca 5
Campinas 5
Caracas 5
Mauá 5
Paris 5
Salvador 5
San José 5
Totale 4.536
Salva come PNG Salva come JPEG
Nome #
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 134
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 124
Inflammation and malnutrition in inflammatory bowel disease 117
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes 104
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation 104
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 103
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 94
Autoimmune pancreatitis: Cornerstones and future perspectives 91
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 89
Italian Chronic Pancreatitis Registry (ITARECIPE): Protocol for a nationwide cohort study 88
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 86
Advancements in Barrett's esophagus detection: The role of artificial intelligence and its implications 85
The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies 85
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study 82
An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma : an unusual association and review of the literature 81
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 80
Acute mesenteric ischemia and small bowel imaging findings in COVID-19: A comprehensive review of the literature 80
Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review: CME 80
ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors. 78
Endoscopic Submucosal Dissection (ESD) for the Management of Fibrotic Non-Lifting Colorectal Lesions (NLCLs): Results from a Large Multicenter Retrospective Study 77
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database 77
Unraveling the Microbiome's Role in Neuroendocrine Neoplasms: A New Perspective 77
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 76
A wait-and-watch approach to small pancreatic neuroendocrine tumors : Prognosis and survival 75
Clinical and biological heterogeneity of Grade 2 digestive neuroendocrine neoplasms: prognostic significance of the 10% Ki-67 index cutoff and implications for treatment strategies. A longitudinal study 75
Advancing transmural remission as a treatment target in Crohn's disease: The future of tight-control strategy? 73
Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity 73
"Pseudotumoral” hepatic pattern in acute alcoholic hepatitis : a case report 71
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials 71
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 70
Occurrence and characteristics of endoscopic gastric polyps in patients with autoimmune gastritis (AGAPE study): A multicentric cross-sectional study 70
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 70
The Role of Therapeutic Endoscopic Ultrasound in Management of Malignant Double Obstruction (Biliary and Gastric Outlet): A Comprehensive Review with Clinical Scenarios 69
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study 69
Autoimmune Pancreatitis Mimicking a Pancreatic Neuroendocrine Tumor: A Case Report with a Literature Review 67
Transforming Gastrointestinal Diagnosis with Molecular Endoscopy: Challenges and Opportunities 67
Endoscopic ultrasound appearance of pancreatic serotonin-staining neuroendocrine neoplasms 67
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 67
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms 66
"Pseudotumoral" hepatic areas in acute alcoholic hepatitis: A computed tomography and histological study 65
An unusual endoscopic feature in the duodenum of a young girl with intraluminal duodenal diverticulum 65
A case of positive 68Ga-DOTATOC-PET/CT pancreatic heterotopia mimicking an intestinal neuroendocrine tumor 64
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor 63
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 62
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights 61
Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review 58
Plasma chromogranin A in patients with inflammatory bowel disease 58
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 58
Endoscopic Ultrasound Elastography in Pancreatic Diseases EUS-EG in Pancreatic Diseases 57
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 57
High rates of 30-day mortality in patients with cirrhosis and COVID-19 56
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms 56
Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis. 56
Endoscopic Resection for Duodenal Neuroendocrine Neoplasms between 10 and 20 mm—A Systematic Review and Meta-Analysis 55
Chromogranin A in diagnosing and monitoring patients with gastro-entero-pancreatic neuroendocrine neoplasms : a large series from a single institution 55
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 54
Small Bowel Ultrasound beyond Inflammatory Bowel Disease: An Updated Review of the Recent Literature 53
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 53
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 53
Should patients with IBS be submitted to painful rectal distention in clinical practice? [1] 51
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 51
Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study 50
CLINICAL AND ENDOSCOPIC-HISTOLOGICAL FEATURES OF MULTIFOCAL AND CORPUS-RESTRICTED ATROPHIC GASTRITIS PATIENTS WITH NONCARDIA GASTRIC CANCER OR DYSPLASIA: A MULTICENTER, CROSS-SECTIONAL STUDY 50
Systematic review-Pancreatic involvement in inflammatory bowel disease 50
Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review 49
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 49
Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience 49
Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm 49
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 48
Hepatic pseudocystic metastasis of well-differentiated ileal neuroendocrine tumor : a case report with review of the literature 48
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 48
Cell Blood Count Alterations and Patterns of Anaemia in Autoimmune Atrophic Gastritis at Diagnosis: A Multicentre Study 48
Drug side-effects in IBD [1] 48
Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: A transversal prospective study 48
Gastric carcinoids : between underestimation and overtreatment 48
Clinical impact of endoscopic ultrasonography on the management of neuroendocrine tumors: lights and shadows 48
Neuroendocrine tumors of the gastro-entero-pancreatic system 48
Neuroendocrine neoplasms of rectum: A management update 47
Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors 47
Circulating ghrelin levels in patients with inflammatory bowel disease [1] 47
Hepatic hemangioma in celiac patients : data from a large consecutive series 46
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 46
The diagnostic challenges of functioning neuroendocrine tumors: balancing accuracy, availability, and personalized care 46
Endoscopic techniques for gastric neuroendocrine tumors: An update 46
Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours : Literature review, clinical recommendations and schedules 45
Gastric neuroendocrine neoplasms and proton pump inhibitors : fact or coincidence? 45
Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are 45
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 45
Clinical Outcome of Patients with Gastric, Duodenal, or Rectal Neuroendocrine Tumors after Incomplete Endoscopic Resection 45
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 44
Endoscopic management of gastric, duodenal and rectal NETs: Position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED) 44
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 44
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 44
IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence 44
The oft-overlooked cardiovascular complications of inflammatory bowel disease 43
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 43
Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B 43
Endoscopic techniques to detect small-bowel neuroendocrine tumors: A literature review 43
Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity 43
Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature 42
Totale 6.278
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.480
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 1 0 1 0 0 0 0 0 1
2022/202360 16 5 3 4 2 9 7 6 4 0 0 4
2023/202448 0 3 2 6 5 6 3 4 3 1 5 10
2024/20251.512 25 2 5 122 41 129 299 98 206 282 137 166
2025/20267.410 529 589 538 848 600 389 715 533 1.832 470 355 12
Totale 9.039